The ACE level was found to be 11.69 ± 1.99 ng/mL in the NAFLD group and 11.52 ± 1.72 ng/mL in the control group (p = 0.70). The gene discussed is ACE; the disease is metabolic dysfunction-associated steatotic liver disease.